Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
9.09
-0.03 (-0.33%)
May 6, 2026, 12:03 PM EDT - Market open
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $494.68 million as of May 6, 2026. Its market cap has increased by 4.94% in one year.
Market Cap
494.68M
Enterprise Value
156.07M
1-Year Change
4.94%
Ranking
Category
Stock Price
$9.09
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $494.68M, an increase of 25.76%. That is a compound annual growth rate of 15.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 506.65M | -65.47% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
| Oct 11, 2024 | 393.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 528.30M |
| Shattuck Labs | 523.03M |
| Verastem | 522.67M |
| enGene Therapeutics | 509.79M |
| Ovid Therapeutics | 507.00M |
| Zura Bio | 504.77M |
| Immix Biopharma | 502.55M |
| Valneva SE | 500.30M |